Ketamine Reimagined: Distinguishing Psychedelic and Psycholytic Modalities for Next-Generation Therapies.
Study at a glance
AI-extracted from the abstract| Characteristics | Review |
|---|---|
| Intervention | Ketamine |
| Topics | Esketamine Ketamine Psychedelic-assisted therapy |
| Key findings | Argues that ketamine's psychedelic and psycholytic therapeutic effects differ mainly as a dose-response effect, and that clarifying the distinct and overlapping benefits of these two paradigms could inform clinical practice and future research in treating depression, anxiety, addictions, and PTSD. The author also proposes further study of ketamine as an enhancement for creativity, teamwork, and collaboration. |
Abstract
This paper explores ketamine as a psychedelic alongside the differential impacts of psychedelic versus psycholytic effects of ketamine in a therapeutic setting. The paper examines existing research to elucidate the broad therapeutic potential of ketamine and the mechanisms underlying each modality. The primary objective is to present the differences between psychedelic and psycholytic applications of ketamine, which is essentially a dose-response effect, focusing on their efficacy in treating mental health disorders such as depression, anxiety, addictions and PTSD. The biochemical interactions and subjective experiences associated with each effect type, contributing to a more developed understanding of ketamine’s therapeutic spectrum is also investigated. This paper seeks to inform clinical practices and future research directions by highlighting the distinct and overlapping benefits of these two paradigms of ketamine when used in therapy. Further research such as the innovative development of the use of ketamine as an enhancement for creativity, teamwork and collaboration alongside other innovative applications have been suggested.